Abstract
In July 2007, 24 members of the Endocrinologic and Metabolic Drug Advisory Committee (EMDAC) and the Drug Safety and Risk Management Advisory Committee of the Food and Drug Administration (FDA) held a joint meeting, which I chaired, and concluded that
Cite
CITATION STYLE
APA
Rosen, C. J. (2010). Revisiting the Rosiglitazone Story — Lessons Learned. New England Journal of Medicine, 363(9), 803–806. https://doi.org/10.1056/nejmp1008233
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free